Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07103733 · ClinicalTrials.gov registry record · NA
PRIMARY Ancillary Substudy
A NA study of Ventricular Arrhythmias and Mitral Valve Prolapse, sponsored by Annetine Gelijns.
- Recruiting
- Registry status
- NA
- Development phase
- 250
- Enrollment target
- 20
- Study locations
NCT07103733 is a NA study of Ventricular Arrhythmias and Mitral Valve Prolapse that is actively recruiting participants, run by Annetine Gelijns. The registered enrollment target is 250 participants. The trial reports 20 study locations across 15 states.
The verdict
NCT07103733, a NA study of Ventricular Arrhythmias and Mitral Valve Prolapse, is actively recruiting participants, sponsored by Annetine Gelijns.
- RECRUITING
- Registry status
- NA
- Development phase
- 250 participants
- Enrollment target
- 20
- Study locations
Study Summary
The PRIMARY trial (NCT05051033), which compares mitral valve repair (MVr) to transcatheter-edge-to-edge-repair (TEER), offers a platform for conducting mechanistic studies to develop early insights into the pathophysiological processes by which mitral valve prolapse (MVP) can impact left ventricular (LV) myocardial structure and function, and, thereby, predispose to arrhythmias and sudden death. Such insights are key to identifying interventions to reduce the long-term sequelae of heart failure (HF) and arrhythmias, as well as delineate optimal therapeutic approaches for different patient sub-groups.
Conditions Studied
Interventions
- PROCEDURE Cardiac Magnetic Resonance Imaging
- DEVICE ZioPatch Monitoring
- PROCEDURE Myocardial Tissue Biopsy
Study Locations (20)
California
- Keck Hospital of the University of Southern California - Los Angeles
- Cedars-Sinai - Los Angeles
- University of California San Francisco - San Francisco
- Stanford University - Stanford
New York
- Weill Cornell Medicine/ New York-Presbyterian Hospital - New York
- Northwell--Lenox Hill, North Shore, South Shore, Staten Island University Hospital - New York
Other
- Deutsches Herzzentrum der Charité - Berlin
- Herzzentrum Leipzig - Leipzig
Georgia
- Piedmont Heart Institute - Atlanta
Maine
- Maine Medical Center - Portland
Maryland
- The Johns Hopkins Hospital - Baltimore
Massachusetts
- Massachusetts General Hospital - Boston
Michigan
- University of Michigan Hospital - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2023-10-16 |
| Est. Completion | 2027-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07103733
The ClinicalTrials.gov registry entry for NCT07103733 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Annetine Gelijns, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Ventricular Arrhythmias appearing as the primary indexed condition, and to 3 interventions - of which Cardiac Magnetic Resonance Imaging is the first listed.
NCT07103733 reports 20 study locations spanning 15 distinct geographic areas - top geographies include California, New York, Other.
Frequently Asked Questions
What is clinical trial NCT07103733 about?
NCT07103733 is a clinical study titled "PRIMARY Ancillary Substudy". The PRIMARY trial (NCT05051033), which compares mitral valve repair (MVr) to transcatheter-edge-to-edge-repair (TEER), offers a platform for conducting mechanistic studies to develop early insights into the pathophysiological processes by which mitral valve prolapse (MVP) can impact left ventricular...
What is the current status of trial NCT07103733?
This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2023-10-16. Estimated completion is 2027-06-30.
What conditions does trial NCT07103733 study?
This clinical trial studies the following conditions: Ventricular Arrhythmias, Mitral Valve Prolapse, Left Ventricular Fibrosis.
What interventions are being tested in trial NCT07103733?
The interventions under investigation include: Cardiac Magnetic Resonance Imaging (PROCEDURE), ZioPatch Monitoring (DEVICE), Myocardial Tissue Biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT07103733?
This trial is sponsored by Annetine Gelijns, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07103733 being conducted?
This trial has 20 study locations across California, Georgia, Maine, Maryland, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ventricular Arrhythmias
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.